New COPD inhaler increases heart attack risk Anjali Nimesh Nimesh4 Jan 2018 7:28 PM ISTPeople with chronic obstructive pulmonary disease (COPD) who use long-acting inhaled bronchodilators may have an increased risk of heart attacks and...
New therapeutic approach for advanced lung disease Anjali Nimesh Nimesh13 Jan 2018 7:10 PM ISTThe study was a cooperative effort between the team headed by assistant professor Dr Jürgen Knobloch from the Medical Clinic III for Pneumology, Sleep...
New study offers insights on genetic indicators of COPD risk Anjali Nimesh Nimesh17 Jan 2018 7:25 PM ISTResearchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but...
COPD patients on long-term ICS have increased risk of bone fractures Anjali Nimesh Nimesh6 Feb 2018 8:00 PM ISTAccording to a new study conducted by Researchers from McGill University and the Jewish General Hospital-Lady Davis Research Institute, long-term...
Azithromycin: A hope ahead for Idiopathic Pulmonary Fibrosis Dr. Kamal Kant Kohli Kohli26 Feb 2018 8:00 PM ISTIdiopathic pulmonary fibrosis (IPF) is a progressive lung disorder of unknown etiology for which there is no available effective therapy.Acute...
Short term oral steroids for acute exacerbations of COPD Anjali Nimesh Nimesh29 March 2018 7:30 PM ISTChronic obstructive pulmonary disease (COPD) is a long-term lung condition that is commonly associated with smoking. Patients with COPD may experience...
BTS Guideline for oxygen use in healthcare Dr. Kamal Kant Kohli Kohli10 April 2018 7:02 PM ISTBritish Thoracic Society has released its Guideline for oxygen use in healthcare and emergency settings.The guidance is based on new evidence about...
Most COPD cases linked to childhood risk factors Anjali Nimesh Nimesh8 April 2018 7:30 PM ISTLifetime lung function is related to the quality of life and longevity and individuals follow different lung function trajectories during the...
Triple vs dual therapy in COPD: the IMPACT trial Anjali Nimesh Nimesh23 April 2018 7:28 PM ISTThe evidence is weak for benefit in COPD of triple therapy comprising long-acting muscarinic antagonist (LAMA), long-acting β2-agonist (LABA), and...
Multimorbidity on the rise & needs to be addressed urgently Anjali Nimesh Nimesh26 April 2018 7:03 PM ISTMultimorbidity is a condition characterized by the presence of two or more chronic medical conditions in an individual. It can present several...
FDA approves Trelegy Ellipta for use in COPD Vinay Singh singh26 April 2018 7:25 PM ISTUS Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol...
9 out of 10 people worldwide breathe polluted air : WHO Anjali Nimesh Nimesh3 May 2018 7:03 PM ISTAir pollution levels remain dangerously high all over e world and according to latest data from WHO, 9 out of 10 people breathe air containing high...
